The BioMark HD System provides the sensitivity required to study gene expression profiles down to the single-cell level and high throughput SNP genotyping and digital PCR for copy number variation and rare mutation detection.
The Access Array System will allow high-throughput, target-enrichment for the major next-generation sequencing instruments and allows users to enrich multiple unique targets from a large number of samples.
Ambry Genetics chief executive officer Charles Dunlop said: "We are ready to unleash the power of Fluidigm platforms and are anxious to offer our customers these enhanced capabilities."
Fluidigm president and chief executive officer Gajus Worthington said: "With the combined expertise, customer focus, and technological prowess of Fluidigm and Ambry, we are confident we wil deliver a new level of value to Ambry’s customers."